PathAI, a Boston, MA-based provider of AI-powered pathology platform has raised $60M in Series B funding led by General Atlantic with strong participation from General Catalyst and other existing investors. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors.Advanced Learning Towards Faster More Accurate Diagnosis of DiseaseCo-founded by Chief Executive Officer Dr. Andy Beck in 2016 with the mission to offer faster, safer and more powerful solutions
Read More